120 related articles for article (PubMed ID: 10891455)
1. CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytolysis.
Shallal S; Kornbluth J
Blood; 2000 Jul; 96(1):224-33. PubMed ID: 10891455
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.
De Bruyne E; Bos TJ; Asosingh K; Vande Broek I; Menu E; Van Valckenborgh E; Atadja P; Coiteux V; Leleu X; Thielemans K; Van Camp B; Vanderkerken K; Van Riet I
Clin Cancer Res; 2008 May; 14(10):2918-26. PubMed ID: 18483358
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD9 antigen on normal activated human B cells.
Zeleznik-Le NJ; Metzgar RS
Cell Immunol; 1989 Oct; 123(1):70-82. PubMed ID: 2673548
[TBL] [Abstract][Full Text] [Related]
4. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
Storkus WJ; Dawson JR
J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
[TBL] [Abstract][Full Text] [Related]
5. Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells.
Katz P; Mitchell SR; Cupps TR; Evans M; Whalen G
Cell Immunol; 1989 Mar; 119(1):130-42. PubMed ID: 2784076
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.
Shimazaki C; Atzpodien J; Wisniewski D; Gulati SC; Kolitz JE; Fried J; Clarkson BD
Acta Haematol; 1988; 80(4):203-9. PubMed ID: 3146198
[TBL] [Abstract][Full Text] [Related]
7. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
[TBL] [Abstract][Full Text] [Related]
8. Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association.
Toyo-oka K; Yashiro-Ohtani Y; Park CS; Tai XG; Miyake K; Hamaoka T; Fujiwara H
Int Immunol; 1999 Dec; 11(12):2043-52. PubMed ID: 10590270
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin production in cultures of pokeweed mitogen stimulated human peripheral blood mononuclear cells requires interaction of interleukin 2 with the B cells.
Ceuppens JL; Stevens EA
Cell Immunol; 1986 Mar; 98(1):1-7. PubMed ID: 3017579
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.
Montel AH; Morse PA; Brahmi Z
Cell Immunol; 1995 Jan; 160(1):104-14. PubMed ID: 7531116
[TBL] [Abstract][Full Text] [Related]
11. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
Trifiletti R; Hyman B; LaVia M; Knapp W; Virella G
Scand J Immunol; 1990 Jan; 31(1):25-31. PubMed ID: 1689073
[TBL] [Abstract][Full Text] [Related]
12. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12.
Rossi AR; Pericle F; Rashleigh S; Janiec J; Djeu JY
Blood; 1994 Mar; 83(5):1323-8. PubMed ID: 7906963
[TBL] [Abstract][Full Text] [Related]
13. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
14. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
Froelich CJ; Guiffaut S
J Immunol; 1987 Dec; 139(11):3637-43. PubMed ID: 2824611
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
[TBL] [Abstract][Full Text] [Related]
16. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW
Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039
[TBL] [Abstract][Full Text] [Related]
17. Expression of the adhesion molecules ICAM-1 and ICAM-2 on tumor cell lines does not correlate with their susceptibility to natural killer cell-mediated cytolysis: evidence for additional ligands for effector cell beta integrins.
Akella R; Hall RE
Eur J Immunol; 1992 Apr; 22(4):1069-74. PubMed ID: 1348028
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation.
Shaw AR; Domanska A; Mak A; Gilchrist A; Dobler K; Visser L; Poppema S; Fliegel L; Letarte M; Willett BJ
J Biol Chem; 1995 Oct; 270(41):24092-9. PubMed ID: 7592610
[TBL] [Abstract][Full Text] [Related]
19. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
Lagaudrière-Gesbert C; Le Naour F; Lebel-Binay S; Billard M; Lemichez E; Boquet P; Boucheix C; Conjeaud H; Rubinstein E
Cell Immunol; 1997 Dec; 182(2):105-12. PubMed ID: 9514697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
